Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...

Adult Stem Cells

Adult Stem Cells

Stem cells are undifferentiated cells that divide and produce more stem cells or progenitor cells that differentiate into mature, specialized cell types. All the cells in the body are generated from stem cells in the early embryo, but small populations of stem cells are also present in many adult tissues including the bone marrow, brain, skin, and gut. These adult stem cells typically produce the various cell types found in that tissue—to replace cells that are damaged or to continuously renew...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Narrowing sex differences in pharmacotherapy following invasive angiography for coronary artery disease between 2017 and 2024.

European heart journal open·2026

Same author

Computational modelling for personalized transcatheter aortic valve replacement planning: a systematic review of complications and decision support.

Frontiers in digital health·2026

Same author

Efficacy of the Shear Stress Pattern Computed in Coronary Artery Reconstruction Models With and Without Side Branches in Predicting Plaque Progression.

Arteriosclerosis, thrombosis, and vascular biology·2026

Same author

Cardiogenic Shock: Clinical Management, Outcomes and Future Directions.

Journal of cardiovascular development and disease·2026

Same author

A randomized crossover clinical trial comparing 24-h blood pressure measurements from two different cuffless wrist ambulatory monitors with cuffed ambulatory monitoring for translation to clinical practice: Rationale and Design of Continuum BP study.

American heart journal plus : cardiology research and practice·2026

Same author

Angiography-derived fractional flow reserve- vs usual care-guided percutaneous coronary intervention: interim analysis of the PIONEER IV trial.

European heart journal·2026

Search research articles

Related Experiment Video

Updated: Jun 10, 2026

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Cardiac stem cell therapy: progress from the bench to bedside.

Matthew J Lovell¹, Anthony Mathur

¹Department of Cardiology, London Chest Hospital, Queen Mary University of London, Barts and the London NHS Trust, London, UK.

Heart (British Cardiac Society)

|July 30, 2010

Summary

This summary is machine-generated.

Translating stem cell therapy for cardiovascular disease from preclinical studies to human application faces significant challenges. This review examines the progress and hurdles in cardiac repair research moving from the lab to clinical practice.

More Related Videos

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Related Experiment Videos

Last Updated: Jun 10, 2026

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Isolation, Characterization, and Differentiation of Cardiac Stem Cells from the Adult Mouse Heart

Published on: January 7, 2019

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Construction of Defined Human Engineered Cardiac Tissues to Study Mechanisms of Cardiac Cell Therapy

Published on: March 1, 2016

Area of Science:

Cardiovascular Research
Regenerative Medicine
Translational Science

Background:

Stem cell therapy shows promise for cardiac repair in preclinical models.
Translating these findings into human treatments for cardiovascular disease is complex.
The transition from laboratory research to clinical application requires careful consideration.

Purpose of the Study:

To review the current progress in translating preclinical stem cell therapy results for cardiovascular disease into human trials.
To identify and discuss the challenges encountered in moving cardiac repair research from bench to bedside.
To stimulate discussion on the critical questions in stem cell therapy development.

Main Methods:

Literature review of preclinical and clinical studies on stem cell therapy for cardiovascular disease.
Analysis of translational challenges and successes in cardiac repair.
Synthesis of current research trends and future directions.

Main Results:

Significant progress has been made in preclinical cardiac repair models.
Several challenges impede the direct translation of these findings to human patients.
The field is actively exploring strategies to overcome these translational barriers.

Conclusions:

The translation of stem cell therapy for cardiovascular disease requires addressing specific challenges.
Further research is needed to bridge the gap between preclinical promise and clinical reality.
Understanding and overcoming bench-to-bedside hurdles is crucial for successful cardiac repair therapies.